Bellerophon Therapeutics (BLPH) Institutional Ownership → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free BLPH Stock Alerts $0.06 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaSustainability Institutional Ownership Changes (13F Filings) for Bellerophon Therapeutics (NASDAQ:BLPH)CurrentInstitutional OwnershipPercentage10.61%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$183.02KNumber ofInstitutional Sellers(last 12 months)0 Get BLPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Bellerophon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLPH Institutional Buying and Selling by Quarter Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Bellerophon Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/7/2023 Acadian Asset Management LLC265,253$182K0.0%N/A2.538% 11/17/2022Telemetry Investments L.L.C.47,500$52K0.1%-31.2%0.497% 7/26/2022 Sepio Capital LP23,800$29K0.0%N/A0.249% 11/16/2021Telemetry Investments L.L.C.85,500$347K0.5%-6.0%0.899% 11/12/2021 Renaissance Technologies LLC201,706$819K0.0%-21.5%2.122% 11/9/2021 BlackRock Inc.120,620$490K0.0%+3.6%1.268% Get the Latest News and Ratings for BLPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellerophon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/17/2021Virtu Financial LLC16,495$80K0.0%N/A0.174% 8/16/2021Telemetry Investments L.L.C.90,920$440K0.6%+48.9%0.956% 8/16/2021 State Street Corp21,027$102K0.0%-63.1%0.221% 8/13/2021 Renaissance Technologies LLC257,072$1.24M0.0%+10.0%2.704% 8/13/2021 Northern Trust Corp36,555$177K0.0%-51.6%0.385% 8/13/2021 Geode Capital Management LLC58,380$282K0.0%-8.0%0.614% 8/13/2021 Vanguard Group Inc.336,966$1.63M0.0%-6.2%3.545% 8/12/2021 JPMorgan Chase & Co.6,507$31K0.0%+242.5%0.068% 8/12/2021Ergoteles LLC13,800$67K0.0%N/A0.145% 5/21/2021 Citadel Advisors LLC20,000$104K0.0%N/A0.210% 5/19/2021 Squarepoint Ops LLC14,569$76K0.0%N/A0.153% 5/18/2021New Mountain Vantage Advisers L.L.C.252,650$3.16M0.1%-75.0%2.658% 5/18/2021 Tudor Investment Corp Et Al20,000$104K0.0%N/A0.210% 5/18/2021 Citadel Advisors LLC20,000$104K0.0%N/A0.210% 5/17/2021 Caas Capital Management LP97,900$508K0.0%N/A1.030% 5/14/2021 Laurion Capital Management LP20,000$104K0.0%N/A0.210% 5/13/2021 Renaissance Technologies LLC233,799$1.21M0.0%+9.1%2.459% 5/12/2021 Northern Trust Corp75,579$393K0.0%-15.7%0.795% 5/11/2021 Element Capital Management LLC11,646$60K0.0%N/A0.123% 5/10/2021 GSA Capital Partners LLP63,566$330K0.1%+6.7%0.669% 5/7/2021 BlackRock Inc.321,782$1.67M0.0%+2.3%3.385% 4/28/2021 DAVENPORT & Co LLC98,975$514K0.0%+10.9%1.041% 2/19/2021 JPMorgan Chase & Co.10,701$72K0.0%+261.4%0.113% 2/12/2021 LPL Financial LLC10,080$67K0.0%N/A0.106% 2/11/2021 Northern Trust Corp89,607$598K0.0%-2.8%0.943% 2/10/2021 Renaissance Technologies LLC214,299$1.43M0.0%-13.7%2.256% 2/9/2021 Wells Fargo & Company MN202,330$1.35M0.0%+83.5%2.130% 2/5/2021 BlackRock Inc.314,617$2.10M0.0%+9.8%3.312% 2/4/2021 GSA Capital Partners LLP59,589$397K0.1%+112.1%0.627% 11/16/2020 AQR Capital Management LLC34,071$347K0.0%N/A0.359% 11/10/2020 State Street Corp59,077$601K0.0%+82.9%0.622% 11/6/2020 GSA Capital Partners LLP28,092$286K0.0%N/A0.296% 11/5/2020 First Trust Advisors LP20,415$208K0.0%N/A0.215% 11/5/2020 Wells Fargo & Company MN110,236$1.12M0.0%+6,163.4%1.161% “Dollar Will Be Worth NOTHING” -Musk (Ad)Elon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now.10/30/2020 WINTON GROUP Ltd12,498$127K0.0%N/A0.132% 10/15/2020 DAVENPORT & Co LLC94,475$962K0.0%-11.8%0.994% 8/25/2020 Nuveen Asset Management LLC21,592$271K0.0%N/A0.227% 8/20/2020 Charles Schwab Investment Management Inc.11,586$146K0.0%N/A0.122% 8/14/2020 Bank of America Corp DE6,501$82K0.0%+49,907.7%0.068% 8/14/2020Telemetry Investments L.L.C.125,000$1.57M4.3%+150.0%1.316% 8/12/2020 American International Group Inc.2,105$26K0.0%N/A0.022% 8/12/2020 Tocqueville Asset Management L.P.25,400$319K0.0%+124.8%0.267% 8/7/2020 New York State Common Retirement Fund8,000$100K0.0%N/A0.084% 7/28/2020 DAVENPORT & Co LLC107,150$1.35M0.0%N/A1.128% 6/24/2020New Mountain Vantage Advisers L.L.C.100,231$16.92M0.9%-99.3%1.635% 5/15/2020 Morgan Stanley2,633$29K0.0%+426.6%0.043% 5/15/2020Telemetry Investments L.L.C.50,000$548K1.9%-85.2%0.815% 5/15/2020New Mountain Vantage Advisers L.L.C.100,231$16.92M0.9%-99.3%1.635% 5/14/2020 Credit Agricole S A3,160$35K0.0%N/A0.052% (Data available from 1/1/2016 forward) BLPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLPH shares? During the previous two years, the following institutional investors and hedge funds held shares of Bellerophon Therapeutics shares: Acadian Asset Management LLC ($182K), and Telemetry Investments L.L.C. ($52K), Sepio Capital LP ($29K).Learn more on BLPH's institutional investors. What percentage of Bellerophon Therapeutics stock is owned by institutional investors? 10.61% of Bellerophon Therapeutics stock is owned by institutional investors. Learn more on BLPH's institutional investor holdings. Which institutional investors have been buying Bellerophon Therapeutics stock? The following institutional investors have purchased Bellerophon Therapeutics stock in the last 24 months: Acadian Asset Management LLC ($265.25K), and Sepio Capital LP ($23.80K). How much institutional buying is happening at Bellerophon Therapeutics? Institutional investors have bought a total of 289,053 shares in the last 24 months. This purchase volume represents approximately $212.30K in transactions. Which Bellerophon Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Bellerophon Therapeutics stock in the last 24 months: Telemetry Investments L.L.C. ($21.50K). How much institutional selling is happening at Bellerophon Therapeutics? Institutional investors have sold a total of 21,500 shares in the last 24 months. This volume of shares sold represents approximately $23.44K in transactions. Related Companies: Aptevo Therapeutics Major Shareholders Aditxt Major Shareholders Evelo Biosciences Major Shareholders Sunshine Biopharma Major Shareholders Athersys Major Shareholders Panbela Therapeutics Major Shareholders Lucy Scientific Discovery Major Shareholders NeuBase Therapeutics Major Shareholders InMed Pharmaceuticals Major Shareholders 180 Life Sciences Major Shareholders This page (NASDAQ:BLPH) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellerophon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.